Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

Bayer1,739 enrolled

Overview

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Study Type

OBSERVATIONAL

Enrollment

1,739

Conditions

Multiple Sclerosis

Interventions

Interferon beta-1b (Betaseron, BAY86-5046)DRUG

Intravenous therapy according to product information

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Multiple sclerosis diagnosed within the last 12 months * Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment

Locations (33)

Unnamed facility

Many Locations, Australia

Unnamed facility

Many Locations, Austria

Outcomes

Primary Outcomes

Physical Activity and Fatigue

Time frame: At baseline and at Month 24

Secondary Outcomes

Health-related Quality of Life

Time frame: At baseline and at Month 24

Depression

Time frame: At baseline and at Month 24

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.